OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumour-infiltrating lymphocytes add prognostic information for patients with low-risk DCIS: findings from the SweDCIS randomised radiotherapy trial
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
European Journal of Cancer (2022) Vol. 168, pp. 128-137
Open Access | Times Cited: 14
Aglaia Schiza, Viktoria Thurfjell, Axel Stenmark Tullberg, et al.
European Journal of Cancer (2022) Vol. 168, pp. 128-137
Open Access | Times Cited: 14
Showing 14 citing articles:
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment
Suzette Delaloge, Seema A. Khan, Jelle Wesseling, et al.
The Lancet (2024) Vol. 403, Iss. 10445, pp. 2734-2746
Closed Access | Times Cited: 11
Suzette Delaloge, Seema A. Khan, Jelle Wesseling, et al.
The Lancet (2024) Vol. 403, Iss. 10445, pp. 2734-2746
Closed Access | Times Cited: 11
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study
Carina Strell, Daniel R. Smith, Antonis Valachis, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 2, pp. 293-299
Open Access | Times Cited: 4
Carina Strell, Daniel R. Smith, Antonis Valachis, et al.
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 2, pp. 293-299
Open Access | Times Cited: 4
A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trial
Haojia Li, Arpit Aggarwal, Paula Toro, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 8, pp. e562-e569
Open Access | Times Cited: 4
Haojia Li, Arpit Aggarwal, Paula Toro, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 8, pp. e562-e569
Open Access | Times Cited: 4
The Microenvironment in DCIS and Its Role in Disease Progression
Mohammad Reza Roozitalab, Niki Prekete, Michael D. Allen, et al.
Advances in experimental medicine and biology (2025), pp. 211-235
Closed Access
Mohammad Reza Roozitalab, Niki Prekete, Michael D. Allen, et al.
Advances in experimental medicine and biology (2025), pp. 211-235
Closed Access
Treatment and Outcome of Ductal Carcinoma in Situ for the German Federal States Berlin and Brandenburg in the Period 2007–2020
Sandy Burmeister, Katarzyna Jóźwiak, Christiane Richter-Ehrenstein, et al.
Geburtshilfe und Frauenheilkunde (2025)
Open Access
Sandy Burmeister, Katarzyna Jóźwiak, Christiane Richter-Ehrenstein, et al.
Geburtshilfe und Frauenheilkunde (2025)
Open Access
Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance
Mieke Van Bockstal, Jelle Wesseling, Ester H. Lips, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Mieke Van Bockstal, Jelle Wesseling, Ester H. Lips, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer
Yuan Li, Jingli Xu, Yunfu Shi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Yuan Li, Jingli Xu, Yunfu Shi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Identifying recurrences and metastasis after ductal carcinoma in situ (DCIS ) of the breast
Ruwangi I Udayasiri, Tongtong Luo, Kylie L. Gorringe, et al.
Histopathology (2022) Vol. 82, Iss. 1, pp. 106-118
Open Access | Times Cited: 8
Ruwangi I Udayasiri, Tongtong Luo, Kylie L. Gorringe, et al.
Histopathology (2022) Vol. 82, Iss. 1, pp. 106-118
Open Access | Times Cited: 8
Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study
Gunilla Rask, Charlotta Wadsten, Balázs Ács, et al.
British journal of surgery (2024) Vol. 111, Iss. 2
Open Access | Times Cited: 1
Gunilla Rask, Charlotta Wadsten, Balázs Ács, et al.
British journal of surgery (2024) Vol. 111, Iss. 2
Open Access | Times Cited: 1
Tumor Heterogeneity Confounds Lymphocyte Metrics in Diagnostic Lung Cancer Biopsies
Hedvig Elfving, Viktoria Thurfjell, Johanna Sofia Margareta Mattsson, et al.
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 1, pp. e18-e24
Open Access | Times Cited: 2
Hedvig Elfving, Viktoria Thurfjell, Johanna Sofia Margareta Mattsson, et al.
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 1, pp. e18-e24
Open Access | Times Cited: 2
Tools to Guide Radiation Oncologists in the Management of DCIS
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, et al.
Healthcare (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, et al.
Healthcare (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial - a study protocol
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, et al.
Research Square (Research Square) (2023)
Open Access
Yasmin A. Civil, Arlene L. Oei, Katya M. Duvivier, et al.
Research Square (Research Square) (2023)
Open Access
